Australia markets close in 2 hours 37 minutes

Australian Clinical Labs Limited (ACL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
2.7700+0.0800 (+2.97%)
As of 01:15PM AEDT. Market open.
Currency in AUD

Valuation measures4

Market cap (intra-day) 542.93M
Enterprise value 839.30M
Trailing P/E 15.07
Forward P/E 14.97
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.78
Price/book (mrq)3.15
Enterprise value/revenue 1.21
Enterprise value/EBITDA 4.81

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 3-22.03%
S&P500 52-week change 324.01%
52-week high 33.8700
52-week low 32.4700
50-day moving average 32.9362
200-day moving average 32.9845

Share statistics

Avg vol (3-month) 3409.48k
Avg vol (10-day) 3509.14k
Shares outstanding 5201.83M
Implied shares outstanding 6201.83M
Float 8117.06M
% held by insiders 112.62%
% held by institutions 166.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.14
Forward annual dividend yield 45.20%
Trailing annual dividend rate 30.14
Trailing annual dividend yield 35.20%
5-year average dividend yield 4N/A
Payout ratio 4268.91%
Dividend date 3N/A
Ex-dividend date 414 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin 5.15%
Operating margin (ttm)8.69%

Management effectiveness

Return on assets (ttm)6.63%
Return on equity (ttm)17.79%

Income statement

Revenue (ttm)697.07M
Revenue per share (ttm)3.47
Quarterly revenue growth (yoy)-26.40%
Gross profit (ttm)N/A
EBITDA 78.5M
Net income avi to common (ttm)35.9M
Diluted EPS (ttm)0.1800
Quarterly earnings growth (yoy)-78.20%

Balance sheet

Total cash (mrq)20.59M
Total cash per share (mrq)0.1
Total debt (mrq)316.32M
Total debt/equity (mrq)183.19%
Current ratio (mrq)0.62
Book value per share (mrq)0.86

Cash flow statement

Operating cash flow (ttm)143.68M
Levered free cash flow (ttm)125.49M